These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14603611)

  • 21. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Beta blocker in endothelial dysfunction. Growth of blood vessel cells is halted].
    MMW Fortschr Med; 2002 Aug; 144(33-34):56. PubMed ID: 12380150
    [No Abstract]   [Full Text] [Related]  

  • 24. Nebivolol in older adults with heart failure: reduced rates for seniors?
    Armstrong PW; Alexander KP
    J Am Coll Cardiol; 2009 Jun; 53(23):2159-61. PubMed ID: 19497442
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta-blockers for hypertension: are they going out of style?
    Che Q; Schreiber MJ; Rafey MA
    Cleve Clin J Med; 2009 Sep; 76(9):533-42. PubMed ID: 19726558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of nebivolol on remodeling of the heart and vessels and the state of hemodynamics in patients with hypertension].
    Gromnatskiĭ NI; Dius'mikeeva NB
    Kardiologiia; 2002; 42(10):27-30. PubMed ID: 12494053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebivolol: a review.
    Cockcroft J
    Expert Opin Pharmacother; 2004 Apr; 5(4):893-9. PubMed ID: 15102571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebivolol: in the treatment of hypertension in the US.
    Baldwin CM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(4):253-60. PubMed ID: 19655820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug approvals: '08 in review. Nebivolol (Bystolic).
    Laustsen G; Carrillo F; Johnson J; Smith C
    Nurse Pract; 2009 Feb; 34(2):25-6. PubMed ID: 19155877
    [No Abstract]   [Full Text] [Related]  

  • 30. Nebivolol: new therapy update.
    Sule SS; Frishman W
    Cardiol Rev; 2006; 14(5):259-64. PubMed ID: 16924166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemodynamic properties of nebivolol].
    Vecchione C; Fratta L; Rozza F; Trimarco G; Selvetella G; Guerrera L; Pilato G; Trimarco B
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):369-72. PubMed ID: 12497937
    [No Abstract]   [Full Text] [Related]  

  • 32. Nebivolol (Bystolic) for hypertension.
    Med Lett Drugs Ther; 2008 Mar; 50(1281):17-9. PubMed ID: 18323772
    [No Abstract]   [Full Text] [Related]  

  • 33. Nebivolol: a third-generation beta-adrenergic blocker.
    Veverka A; Nuzum DS; Jolly JL
    Ann Pharmacother; 2006; 40(7-8):1353-60. PubMed ID: 16822893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of arterial and renal nitric oxide bioavailability in hypertensive rats with diabetes: effect of beta-blockers.
    Mason RP; Kubant R; Jacob RF; Malinski P; Huang X; Louka FR; Borowiec J; Mizuno Y; Malinski T
    Am J Hypertens; 2009 Nov; 22(11):1160-6. PubMed ID: 19730416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D; Papademetriou V
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The editor's roundtable: revisiting the role of beta blockers in hypertension.
    Roberts WC; Black HR; Bakris GL; Mason RP; Giles TD; Sulkes DJ
    Am J Cardiol; 2007 Jul; 100(2):253-67. PubMed ID: 17631080
    [No Abstract]   [Full Text] [Related]  

  • 37. Evolving mechanisms of action of beta blockers: focus on nebivolol.
    Mason RP; Giles TD; Sowers JR
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep quality in patients with hypertension: additional negative effect of drug therapy.
    Yontar OC; Erdem A; Yilmaz MB
    Sleep Med; 2009 Dec; 10(10):1168; author reply 1168-9. PubMed ID: 19467925
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.
    Papademetriou V
    Am J Cardiol; 2009 Jan; 103(2):273-8. PubMed ID: 19121451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade "Stop or Encore?".
    Balligand JL
    J Am Coll Cardiol; 2009 Apr; 53(17):1539-42. PubMed ID: 19389565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.